Detalhe da pesquisa
1.
CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.
Brain
; 143(3): 783-799, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32185393
2.
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Brain
; 141(2): 521-534, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29253099
3.
Reply: CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort.
Brain
; 143(8): e68, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666099
4.
DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.
Mov Disord
; 29(13): 1606-14, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375821
5.
Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?
Brain
; 138(Pt 10): e385, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953780
6.
Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.
Sci Rep
; 11(1): 14881, 2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290285
7.
Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
Ann Neurol
; 64(4): 446-54, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18991351
8.
Effect of Fluvoxamine on Amyloid-ß Peptide Generation and Memory.
J Alzheimers Dis
; 62(4): 1777-1787, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29614681
9.
No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
Neuroreport
; 18(12): 1267-9, 2007 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-17632280
10.
Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.
PLoS One
; 11(6): e0157924, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27336847
11.
Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
Curr Alzheimer Res
; 12(8): 745-51, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26159201
12.
Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease.
Neuroreport
; 13(5): 601-4, 2002 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-11973454
13.
Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.
J Neurol
; 251(9): 1098-104, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15372253
14.
Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.
Dis Model Mech
; 6(5): 1198-204, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23798570
15.
C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients.
PLoS One
; 8(2): e56899, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23437264
16.
C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
Neurology
; 79(10): 995-1001, 2012 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875086
17.
Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease.
Curr Alzheimer Res
; 8(7): 765-70, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21605063
18.
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
Ann Neurol
; 58(6): 829-39, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16315267
19.
Tau haplotypes regulate transcription and are associated with Parkinson's disease.
Ann Neurol
; 55(3): 329-34, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14991810
20.
Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy.
J Biol Chem
; 278(9): 6748-54, 2003 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12493737